Skip to content
MARKETS / NASDAQ / SNES
NASDAQ · AGRICULTURAL CHEMICALS · SMALL CAP

SenesTech, Inc. SNES

11 fiscal years on record · USD · FY2025 reported · SEC filings only
$2.2M
▲ 19.6% YoY
$-6.4M
$-5.9M
In brief

What this company does

We have developed and are commercializing products for managing animal pest populations through fertility control and population management strategies. Our current products focus on rat and mouse populations, and are known as: ContraPest, Evolve Rat, and Evolve Mouse. The Evolve product line launched in January 2024 as Evolve Rat and is currently our primary revenue-generating product. We were originally incorporated in the State of Nevada in July 2004, and in November 2015, we reincorporated in the State of Delaware. Our corporate headquarters and manufacturing site are in Surprise, Arizona. In December 2016, we went public and are currently traded on Nasdaq under the symbol SNES. As of December 31, 2025, we had 23 full-time employees and one part-time employee.

Written from the business description in SenesTech, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 13 March 2026. Every sentence was checked against that document before publication.

Growth
USD 2.2M
Revenue, FY2025 · full 11-year series below
Revenue $M Net income $M
FY2025 · Revenue 2.2 · Net income -6.4
0.8M1.6M-8.0M-16.0M201520172019202120232025
Compound annual growth
+29.7%
+51.1%
+24.9%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +51.1% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
−287 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -292.9% · Net -287.4%
-10000%-20000%201520172019202120232025
ROE
FY2025 · ROE -105.7%
-100%-200%201520172019202120232025

Each USD of equity lost 106 cents this year.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -5.9
-4M-8M201520172019202120232025

Total assetsUSD 12.8M
EquityUSD 9.6M
CashUSD 7.6M
Current ratio12.61×

Equity funds 74% of total assets.

The 11-year record
11 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative
Metric 20252024202320222021202020192018201720162015
Revenue $B0.00.00.00.00.00.00.00.00.00.00.0
Operating income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EBITDA $B−0.0−0.0−0.0−0.0−0.0······
Income tax $B0.00.0·········
Net income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Free cash flow $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EPS, diluted $−1.95−8.86−115.10−148.08−14.77−2.78−7.69−12.62−1.12−1.71−4.71
Dividend / sh $···········
Payout %···········
ROE %−105.7−139.6−132.6−126.6−118.8−259.6−225.6−172.1−133.9··
Shares out B0.010.000.000.000.000.010.000.000.020.010.00

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 53 reconciliationsAUDITED

Reconciled in 11 of 19 fiscal years. 42 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityAgricultural Chemicals
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2015

Share this section

Download image